CHEMED CORP (CHE) Fundamental Analysis & Valuation
NYSE:CHE • US16359R1032
Current stock price
422.16 USD
-2.82 (-0.66%)
At close:
422.16 USD
0 (0%)
After Hours:
This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHE Profitability Analysis
1.1 Basic Checks
- CHE had positive earnings in the past year.
- CHE had a positive operating cash flow in the past year.
- CHE had positive earnings in each of the past 5 years.
- CHE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- CHE has a Return On Assets of 16.91%. This is amongst the best in the industry. CHE outperforms 100.00% of its industry peers.
- CHE has a Return On Equity of 30.64%. This is amongst the best in the industry. CHE outperforms 95.05% of its industry peers.
- CHE has a Return On Invested Capital of 21.50%. This is amongst the best in the industry. CHE outperforms 96.04% of its industry peers.
- CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.40%.
- The last Return On Invested Capital (21.50%) for CHE is above the 3 year average (21.04%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.91% | ||
| ROE | 30.64% | ||
| ROIC | 21.5% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
1.3 Margins
- CHE's Profit Margin of 10.23% is amongst the best of the industry. CHE outperforms 96.04% of its industry peers.
- In the last couple of years the Profit Margin of CHE has declined.
- CHE's Operating Margin of 13.69% is amongst the best of the industry. CHE outperforms 87.13% of its industry peers.
- In the last couple of years the Operating Margin of CHE has declined.
- CHE has a better Gross Margin (32.38%) than 65.35% of its industry peers.
- CHE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.69% | ||
| PM (TTM) | 10.23% | ||
| GM | 32.38% |
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
2. CHE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
- Compared to 1 year ago, CHE has less shares outstanding
- CHE has less shares outstanding than it did 5 years ago.
- CHE has a worse debt/assets ratio than last year.
2.2 Solvency
- CHE has an Altman-Z score of 10.49. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
- CHE's Altman-Z score of 10.49 is amongst the best of the industry. CHE outperforms 95.05% of its industry peers.
- CHE has a debt to FCF ratio of 0.24. This is a very positive value and a sign of high solvency as it would only need 0.24 years to pay back of all of its debts.
- The Debt to FCF ratio of CHE (0.24) is better than 92.08% of its industry peers.
- CHE has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
- CHE has a better Debt to Equity ratio (0.11) than 75.25% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.24 | ||
| Altman-Z | 10.49 |
ROIC/WACC2.38
WACC9.04%
2.3 Liquidity
- A Current Ratio of 0.85 indicates that CHE may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.85, CHE is doing worse than 80.20% of the companies in the same industry.
- A Quick Ratio of 0.83 indicates that CHE may have some problems paying its short term obligations.
- CHE has a Quick ratio of 0.83. This is in the lower half of the industry: CHE underperforms 75.25% of its industry peers.
- CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.83 |
3. CHE Growth Analysis
3.1 Past
- CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.32%.
- Measured over the past 5 years, CHE shows a small growth in Earnings Per Share. The EPS has been growing by 3.61% on average per year.
- Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 2.07% in the last year.
- CHE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.00% yearly.
EPS 1Y (TTM)-8.32%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%0.36%
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%1.63%
3.2 Future
- Based on estimates for the next years, CHE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
- The Revenue is expected to grow by 5.67% on average over the next years.
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. CHE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 19.54 indicates a rather expensive valuation of CHE.
- Based on the Price/Earnings ratio, CHE is valued a bit cheaper than the industry average as 70.30% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 26.64, CHE is valued a bit cheaper.
- A Price/Forward Earnings ratio of 15.70 indicates a correct valuation of CHE.
- Based on the Price/Forward Earnings ratio, CHE is valued a bit cheaper than 70.30% of the companies in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 21.36. CHE is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.54 | ||
| Fwd PE | 15.7 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
- 70.30% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.36 | ||
| EV/EBITDA | 15.1 |
4.3 Compensation for Growth
- CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.67
PEG (5Y)5.41
EPS Next 2Y11.6%
EPS Next 3Y10.57%
5. CHE Dividend Analysis
5.1 Amount
- CHE has a yearly dividend return of 0.56%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.46, CHE pays a better dividend. On top of this CHE pays more dividend than 81.19% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.80, CHE's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
5.2 History
- On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
- CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
- CHE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.06%
Div Incr Years17
Div Non Decr Years22
5.3 Sustainability
- 12.53% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
- The dividend of CHE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP12.53%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
CHE Fundamentals: All Metrics, Ratios and Statistics
422.16
-2.82 (-0.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)04-23 2026-04-23/amc
Earnings (Next)07-27 2026-07-27
Inst Owners104.27%
Inst Owner Change-0.08%
Ins Owners1.51%
Ins Owner Change-1.34%
Market Cap6.17B
Revenue(TTM)2.54B
Net Income(TTM)259.78M
Analysts75
Price Target451.86 (7.04%)
Short Float %3%
Short Ratio1.56
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.56% |
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP12.53%
Div Incr Years17
Div Non Decr Years22
Ex-Date02-23 2026-02-23 (0.6)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.28%
Min EPS beat(2)-10.06%
Max EPS beat(2)5.5%
EPS beat(4)1
Avg EPS beat(4)-5.64%
Min EPS beat(4)-15.11%
Max EPS beat(4)5.5%
EPS beat(8)2
Avg EPS beat(8)-3.57%
EPS beat(12)4
Avg EPS beat(12)-2.58%
EPS beat(16)7
Avg EPS beat(16)-1.87%
Revenue beat(2)1
Avg Revenue beat(2)-1.89%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)0.18%
Revenue beat(4)1
Avg Revenue beat(4)-1.87%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)0.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)2
Avg Revenue beat(12)-1.37%
Revenue beat(16)3
Avg Revenue beat(16)-1.23%
PT rev (1m)0%
PT rev (3m)-22.86%
EPS NQ rev (1m)1.8%
EPS NQ rev (3m)-6.58%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)0.56%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.54 | ||
| Fwd PE | 15.7 | ||
| P/S | 2.43 | ||
| P/FCF | 16.36 | ||
| P/OCF | 13.9 | ||
| P/B | 7.27 | ||
| P/tB | 77.02 | ||
| EV/EBITDA | 15.1 |
EPS(TTM)21.61
EY5.12%
EPS(NY)26.89
Fwd EY6.37%
FCF(TTM)25.81
FCFY6.11%
OCF(TTM)30.37
OCFY7.19%
SpS173.89
BVpS58.04
TBVpS5.48
PEG (NY)1.67
PEG (5Y)5.41
Graham Number167.993 (-60.21%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.91% | ||
| ROE | 30.64% | ||
| ROCE | 28.64% | ||
| ROIC | 21.5% | ||
| ROICexc | 21.8% | ||
| ROICexgc | 60.78% | ||
| OM | 13.69% | ||
| PM (TTM) | 10.23% | ||
| GM | 32.38% | ||
| FCFM | 14.84% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score5
Asset Turnover1.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.11 | ||
| Debt/FCF | 0.24 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 101.42% | ||
| Cap/Sales | 2.62% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.32% | ||
| Profit Quality | 145.17% | ||
| Current Ratio | 0.85 | ||
| Quick Ratio | 0.83 | ||
| Altman-Z | 10.49 |
F-Score5
WACC9.04%
ROIC/WACC2.38
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.32%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%0.36%
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)2.07%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%1.63%
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.06%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y24.72%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y25.23%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%
CHEMED CORP / CHE Fundamental Analysis FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 6 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
What is the profitability of CHE stock?
CHEMED CORP (CHE) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for CHE stock?
The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 19.54 and the Price/Book (PB) ratio is 7.27.
What is the financial health of CHEMED CORP (CHE) stock?
The financial health rating of CHEMED CORP (CHE) is 7 / 10.